![]() |
Volumn 16, Issue 5, 2012, Pages 553-555
|
Treating diabetes by blocking a vascular growth factor
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FATTY ACID;
GLUCAGON;
GLUCOSE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
VASCULOTROPIN ANTIBODY;
VASCULOTROPIN B;
VASCULOTROPIN B ANTIBODY;
BODY WEIGHT;
CARDIOVASCULAR RISK;
CELL DEATH;
CHOLESTEROL BLOOD LEVEL;
DIABETES MELLITUS;
DIABETIC NEUROPATHY;
DISEASE EXACERBATION;
DYSLIPIDEMIA;
ENDOTHELIUM CELL;
FATTY ACID BLOOD LEVEL;
GLUCAGON RELEASE;
GLUCOSE BLOOD LEVEL;
GLUCOSE TOLERANCE;
GLUCOSE TRANSPORT;
GLYCEMIC CONTROL;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REVASCULARIZATION;
HYPERGLYCEMIA;
INSULIN RELEASE;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
ISCHEMIC HEART DISEASE;
LIPID STORAGE;
LIPID TRANSPORT;
NEOVASCULARIZATION (PATHOLOGY);
NERVOUS SYSTEM DEVELOPMENT;
NEUROPROTECTION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PANCREAS ISLET;
PHARMACOLOGICAL BLOCKING;
PRIORITY JOURNAL;
PROTEIN DEFICIENCY;
REVIEW;
RISK REDUCTION;
SAFETY;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 84871402833
PISSN: 15504131
EISSN: 19327420
Source Type: Journal
DOI: 10.1016/j.cmet.2012.10.015 Document Type: Short Survey |
Times cited : (11)
|
References (10)
|